Skip to main content
SpringerLink
Log in

The role of NM23 in patients with colorectal cancer: A systematic review and meta-analysis

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

This meta-analysis was carried out to evaluate the relationship between NM23 expression and the prognosis of patients with colorectal cancer. We searched PubMed, EMBASE and Web of Science for relevant articles. The pooled odd ratios (ORs) and corresponding 95%CI were calculated to evaluate the prognostic value of NM23 expression in patients with colorectal cancer, and the association between NM23 expression and clinicopathological factors. In total, 2289 patients were pooled from 24 available studies. The incorporative OR combined by 16 studies with overall survival showed that high NM23 expression was associated with better overall survival (OR=0.67, 95%CI: 0.49–0.93, P=0.02, I 2=56%, Ph=0.004). And a new estimate without heterogeneity was produced when only combining high-quality studies (OR=0.70, 95%CI: 0.56–0.86, P=0.0007, I 2=46%). In disease free survival (DFS), we also obtained a good prognosis (OR=0.30, 95%CI: 0.14–0.68, P=0.004). Although we failed to find any significance in N status (P=0.10), elevated NM23 expression was related to well tumor differentiation (OR=0.60, 95%CI: 0.44–0.820, P=0.001) and Dukes’ A&B (OR=0.55, 95%CI: 0.32–0.95, P=0.03). These results indicated that over-expressed NM23 might be an indicator of good prognosis, well tumor differentiation and Dukes’ A&B of patients with colorectal cancer, but no significance was found in N status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin, 2015,65(1): 5–29

    Article  PubMed  Google Scholar 

  2. Ng L, Poon RT, Pang R. Biomarkers for predicting future metastasis of human gastrointestinal tumors. Cell Mol Life Sci, 2013,70(19): 3631–3656

    Article  CAS  PubMed  Google Scholar 

  3. Hari DM, Leung AM, Lee JH, et al. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? J Am Coll Surg, 2013,217(2): 181–190

    Article  PubMed  PubMed Central  Google Scholar 

  4. Jensen SL, Wood DP, Banks ER, et al. Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate. World J Urol, 1996,14(Suppl 1):S21–25

    Article  PubMed  Google Scholar 

  5. Khan MH, Yasuda M, Higashino F, et al. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol, 2001,158(5): 1785–1791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gao QL, Ma D, Meng L, et al. Association between Nm23-H1 gene expression and metastasis of ovarian carcinoma. Ai Zheng (Chinese), 2004,23(6): 650–654

    CAS  Google Scholar 

  7. Leone A, Flatow U, King CR, et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 1991,65(1): 25–35

    Article  CAS  PubMed  Google Scholar 

  8. Boissan M, de Wever O, Lizarraga F, et al. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res, 2010,70(19): 7710–7722

    Article  CAS  PubMed  Google Scholar 

  9. Kushlinskii NE, Yurchenko AA, Delektorskaya VV, et al. Relationship between expression of NM23 protein and clinical morphological factors and content of plasminogen activation system components in tumors of patients with gastric cancer. Bull Exp Biol Med, 2007,143(6): 733–736

    Article  CAS  PubMed  Google Scholar 

  10. Kim HJ, Kang HJ, Lee H, et al. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res, 2009,8(3): 1368–1379

    Article  CAS  PubMed  Google Scholar 

  11. Elagoz S, Egilmez R, Koyuncu A, et al. The intratumoral microvessel density and expression of bFGF and nm23-H1 in colorectal cancer. Pathol Oncol Res, 2006,12(1): 21–27

    Article  CAS  PubMed  Google Scholar 

  12. Youn BS, Kim DS, Kim JW, et al. NM23 as a prognostic biomarker in ovarian serous carcinoma. Modern Pathology, 2008,21(7): 885–892

    Article  CAS  PubMed  Google Scholar 

  13. Yang T, Chen BZ, Li DF, et al. Reduced NM23 protein level correlates with worse clinicopathologic features in colorectal cancers: a meta-analysis of pooled data. Medicine (Baltimore), 2016,95(4):pe2589

    Article  Google Scholar 

  14. Han W, Ma J, Cao F, et al. Prognostic value of NM23 in patients with colorectal carcinoma: a systematic review and meta-analysis. PROSPERO, CRD42015029488.

  15. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010,25(9): 603–605

    Article  PubMed  Google Scholar 

  16. Wong WC, Cheung CS, Hart GJ. Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg Themes Epidemiol, 2008,5:23

    Article  PubMed  PubMed Central  Google Scholar 

  17. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997,315(7109): 629–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Garinis GA, Manolis EN, Spanakis NE, et al. High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas. J Mol Med, 2003,81(4): 256–263

    Article  CAS  PubMed  Google Scholar 

  19. Myeroff LL, Markowitz SD. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst, 1993,85(2): 147–152

    Article  CAS  PubMed  Google Scholar 

  20. Nobili S, Napoli C, Landini I, et al. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer. Int J Cancer, 2011,128(8): 1935–1945

    Article  CAS  PubMed  Google Scholar 

  21. Cohn KH, Ornstein DL, Wang FS, et al. The significance of allelic deletions and aneuploidy in colorectal carcinoma–Results of a 5-year follow-up study. Cancer, 1997,79(2): 233–244

    Article  CAS  PubMed  Google Scholar 

  22. Caligo MA, Ghimenti C, Sensi E, et al. Microsatellite alterations and K-ras, TGF beta RII, IGFRII and bax mutations in sporadic cancers of the gastrointestinal tract. Oncol Rep, 2000,7(6): 1371–1375

    CAS  PubMed  Google Scholar 

  23. Cohn KH, Wang F, DeSoto-LaPaix F, et al. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet, 1991,338(8769): 722–724

    Article  CAS  PubMed  Google Scholar 

  24. Lamb RF, Going JJ, Pickford I, et al. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver. Cancer Res, 1996,56(4): 916–920

    CAS  PubMed  Google Scholar 

  25. Leggett B, Young J, Buttenshaw R, et al. Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. Br J Cancer, 1995,71(5): 1070–1073

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Berney CR, Fisher RJ, Yang JI, et al. Protein markers in colorectal cancer–Predictors of liver metastasis. Ann Surg, 1999,230(2): 179–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Abad A, Ojanguren I, Font A, et al. Prognostic significance of the nm23-H1 protein expression in colorectal cancer. Eur J Cancer, 1996,32A(Suppl 1):S26–S26

    Google Scholar 

  28. Ayhan A, Yasui W, Yokozaki H, et al. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases inhuman colorectal carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol, 1993,63(4): 213–218

    Article  CAS  PubMed  Google Scholar 

  29. Berney CR, Yang JL, Fisher RJ, et al. Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival. World J Surg, 1998,22(5): 484–490

    Article  CAS  PubMed  Google Scholar 

  30. Bertucci F, Salas S, Eysteries S, et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene, 2004,23(7): 1377–1391

    Article  CAS  PubMed  Google Scholar 

  31. Cheah PY, Cao X, Eu KW, et al. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas. Br J Cancer, 1998,77(7): 1164–1168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Chen WC, Lin MS, Zhang BF, et al. Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray. World J Gastroenterol, 2007, 13(5): 699–708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Dursun A, Akyurek N, Gunel N, et al. Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology, 2002,34(5): 427–432

    Article  CAS  PubMed  Google Scholar 

  34. Heys SD, Langlois N, Smith IC, et al. NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer. Oncol Rep, 1998,5(3): 735–739

    CAS  PubMed  Google Scholar 

  35. Ichikawa W. Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer. Pathobiology, 1994,62(4): 172–179

    Article  CAS  PubMed  Google Scholar 

  36. Kapitanovic S, Cacev T, Berkovic M, et al. Nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clin Pathol, 2004,57(12): 1312–1318

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Lee JC, Lin YJ, Chow NH, et al. Reappraisal of the role of NM23-H1 in colorectal cancers. J Surg Oncol, 2001,76(1): 58–62

    Article  CAS  PubMed  Google Scholar 

  38. Lindmark G. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer, 1996,74(9): 1413–1418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Madbouly KM, Senagore AJ, Mukerjee A, et al. Does immunostaining effectively upstage colorectal cancer by identifying micrometastatic nodal disease? Int J Colorectal Dis, 2007,22(1): 39–48

    Article  PubMed  Google Scholar 

  40. Martinez J, Prevot S, Nordinger B, et al. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut, 1995, 37(5): 712–720

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Messinetti S, Giacomelli L, Fabrizio G, et al. CD44v6 and Nm23-H1 protein expression related to clinico pathological parameters in colorectal cancer. Ann Ital Chir, 2003,74(1): 45–51

    CAS  PubMed  Google Scholar 

  42. Oliveira LA, Artigiani-Neto R, Waisberg DR, et al. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival. Arq Gastroenterol, 2010,47(4), 361–367

    Article  PubMed  Google Scholar 

  43. Pasz-Walczak G, Salagacka A, Potemski P, et al. Maspin and Nm23-H1 expression in colorectal cancer. Neoplasma, 2010,57(2): 95–101

    Article  CAS  PubMed  Google Scholar 

  44. Su ZH, Li JC. Lymphatic metastasis and nm23H1 genetic instability in Chinese colon cancer patients. World J Gastroenterol, 2004,10(19): 2800–2804

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Tabuchi Y, Nakamura T, Kuniyasu T, et al. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival. Surg Today, 1999,29(2): 116–120

    Article  CAS  PubMed  Google Scholar 

  46. Tannapfel A, Kockerling F, Katalinic A, et al. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum, 1995,38(6): 651–654

    Article  CAS  PubMed  Google Scholar 

  47. Tripkovic A, Tripkovic I, Tomic S, et al. The role of nm23 gene in colorectal carcinogenesis. Acta Clin Croat, 2012,51(1): 43–49

    PubMed  Google Scholar 

  48. Wu HW, Gao LD, Wei GH. hMSH2 and nm23 expression in sporadic colorectal cancer and its clinical significance. Asian Pac J Cancer Prev, 2013,14(3): 1995–1998

    Article  PubMed  Google Scholar 

  49. Yamaguchi A, Urano T, Fushida S, et al. Inverse association of nm23-H1 expression by colorectal-cancer with liver metastasis. Br J Cancer, 1993,68(5): 1020–1024

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Yang YQ, Wu L, Chen JX, et al. Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients. World J Gastroenterol, 2008,14(36): 5549–5556; discussion 5555

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Lin XQ, Liang Y, Ding SP, et al. Genetic instability on chromosome 17q21 in gastric cancer of Chinese patients. Shi Yan Sheng Wu Xue Bao (Chinese), 2005,38(2): 148–156

    CAS  Google Scholar 

  52. Chen J, Zhou Q, Qin Y, et al. A study on the allelic deletion of nm23 genes in human lung cancer. Zhongguo Fei Ai Za Zhi, 2000,3(1): 8–13

    CAS  PubMed  Google Scholar 

  53. Lu HY, Zhang GQ, Li JC. Study on genetic instability of nm23H1 gene in Chinese with original gallbladder tumor. Fen Zi Xi Bao Sheng Wu Xue Bao (Chinese), 2006,39(3): 249–257

    CAS  Google Scholar 

  54. Qin Z, Dai L, Toole B, et al. Regulation of Nm23-H1 and cell invasiveness by Kaposi’s sarcoma-associated herpesvirus. J Virol, 2011,85(7): 3596–3606

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Marshall JC, Collins J, Marino N, et al. The Nm23-H1 metastasis suppressor as a translational target. Eur J Cancer, 2010,46(7): 1278–1282

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Boissan M, Lacombe ML. Nm23/NDP kinases in hepatocellular carcinoma. J Bioenerg Biomembr, 2006,38(3-4): 169–175

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Kunshan First People’s Hospital Affiliated to Jiangsu University, Kunshan, 215300, China

    Wei Han  (韩 玮), Fang Cao  (曹 方), Rong Zhu  (朱 荣), Yong-wei Hu  (胡永伟) & Hou-zhong Ding  (丁厚中)

  2. Department of Urinary Surgery, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, 215300, China

    Jun Ma  (马 俊) & Cong Zhang  (张 聪)

  3. Department of Radiotherapy and Oncology, Kunshan First People’s Hospital Affiliated to Jiangsu University, Kunshan, 215300, China

    Min-bin Chen  (陈敏斌)

Authors
  1. Wei Han  (韩 玮)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Ma  (马 俊)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fang Cao  (曹 方)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cong Zhang  (张 聪)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rong Zhu  (朱 荣)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yong-wei Hu  (胡永伟)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Min-bin Chen  (陈敏斌)
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hou-zhong Ding  (丁厚中)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hou-zhong Ding  (丁厚中).

Additional information

These authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, W., Ma, J., Cao, F. et al. The role of NM23 in patients with colorectal cancer: A systematic review and meta-analysis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 37, 1–10 (2017). https://doi.org/10.1007/s11596-017-1686-z

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-017-1686-z

Key words

Search

Navigation